Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide

Neuroscience

Volumn 151, Issue 1, 2008, Pages 63-73

  Armstrong, B D ^a   Abad, C ^a   Chhith, S ^a   Cheung Lau, G ^a   Hajji, O E ^a   Nobuta, H ^a   Waschek, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

facial motor nucleus; microglia; neuroinflammation; PACAP; regeneration; VIP

Indexed keywords

GAMMA INTERFERON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FACIAL NERVE INJURY; HYPOPHYSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; MOTONEURON; MOTONEURON NUCLEUS; MOUSE; NERVE FIBER; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; WILD TYPE;

ANIMALS; AXOTOMY; BRAIN STEM; CELL SURVIVAL; CYTOKINES; FACIAL NERVE; GALANIN; GAP-43 PROTEIN; GLIOSIS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MOTOR NEURONS; NERVE CRUSH; NERVE REGENERATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; STILBAMIDINES;

EID: 37849010501     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.09.084     Document Type: Article

References (40)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 94 (1946) 239-247
2. Arimura A., Somogyvari-Vigh A., Weill C., Fiore R.C., Tatsuno I., Bay V., and Brenneman D.E. PACAP functions as a neurotrophic factor. Ann N Y Acad Sci 739 (1994) 228-243
3. Armstrong B.D., Abad C., Chhith S., Cheung-Lau G., Hajji O.E., Coute A.C., Ngo D.H., and Waschek J.A. Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice. Neuroreport 17 (2006) 309-312
4. Armstrong B.D., Abad C., Chhith S., Rodriguez W., Cheung-Lau G., Trinh V., and Waschek J.A. Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes. Neuroreport 15 (2004) 2647-2650
5. Armstrong B.D., Hu Z., Abad C., Yamamoto M., Rodriguez W.I., Cheng J., Lee M., Chhith S., Gomariz R.P., and Waschek J.A. Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice. Neuroscience 129 (2004) 93-99
6. Armstrong B.D., Hu Z., Abad C., Yamamoto M., Rodriguez W.I., Cheng J., Tam J., Gomariz R.P., Patterson P.H., and Waschek J.A. Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosci Res 74 (2003) 240-247
7. Atlasz T., Babai N., Kiss P., Reglodi D., Tamas A., Szabadfi K., Toth G., Hegyi O., Lubics A., and Gabriel R. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats. Gen Comp Endocrinol 153 (2007) 108-114
8. Botia B., Basille M., Allais A., Raoult E., Falluel-Morel A., Galas L., Jolivel V., Wurtz O., Komuro H., Fournier A., Vaudry H., Burel D., Gonzalez B.J., and Vaudry D. Neurotrophic effects of PACAP in the cerebellar cortex. Peptides 28 (2007) 1746-1752
9. Chen Y., Samal B., Hamelink C.R., Xiang C.C., Chen Y., Chen M., Vaudry D., Brownstein M.J., Hallenbeck J.M., and Eiden L.E. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept 137 (2006) 4-19
10. Colwell C.S., Michel S., Itri J., Rodriguez W., Tam J., Lelievre V., Hu Z., and Waschek J.A. Selective deficits in the circadian light response in mice lacking PACAP. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1194-R1201
11. Deboy C.A., Xin J., Byram S.C., Serpe C.J., Sanders V.M., and Jones K.J. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells. Exp Neurol 201 (2006) 212-224
12. Delgado M., and Ganea D. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J 17 (2003) 1922-1924
13. Delgado M., Leceta J., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J Immunol 163 (1999) 3629-3635
14. Delgado M., Pozo D., and Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56 (2004) 249-290
15. Guirland C., Buck K.B., Gibney J.A., DiCicco-Bloom E., and Zheng J.Q. Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide. J Neurosci 23 (2003) 2274-2283
16. Kato H., Ito A., Kawanokuchi J., Jin S., Mizuno T., Ojika K., Ueda R., and Suzumura A. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult Scler 10 (2004) 651-659
17. Khoury S.J., Hancock W.W., and Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176 (1992) 1355-1364
18. Kimura H., Kawatani M., Ito E., and Ishikawa K. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig. Laryngoscope 113 (2003) 1000-1006
19. Lazarov-Spiegler O., Solomon A.S., and Schwartz M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 24 (1998) 329-337
20. Lee M., Lelievre V., Zhao P., Torres M., Rodriguez W., Byun J.Y., Doshi S., Ioffe Y., Gupta G., de los Monteros A.E., de Vellis J., and Waschek J. Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors. J Neurosci 21 (2001) 3849-3859
21. Makwana M., and Raivich G. Molecular mechanisms in successful peripheral regeneration. FEBS J 272 (2005) 2628-2638
22. Moalem G., Monsonego A., Shani Y., Cohen I.R., and Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J 13 (1999) 1207-1217
23. Moran L.B., and Graeber M.B. The facial nerve axotomy model. Brain Res Brain Res Rev 44 (2004) 154-178
24. Ohtaki H., Nakamachi T., Dohi K., Aizawa Y., Takaki A., Hodoyama K., Yofu S., Hashimoto H., Shintani N., Baba A., Kopf M., Iwakura Y., Matsuda K., Arimura A., and Shioda S. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci U S A 103 (2006) 7488-7493
25. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., and Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18 (1998) 5804-5816
26. Reglodi D., Somogyvari-Vigh A., Vigh S., Maderdrut J.L., and Arimura A. Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions. Ann N Y Acad Sci 921 (2000) 119-128
27. Reglodi D., Tamas A., Somogyvari-Vigh A., Szanto Z., Kertes E., Lenard L., Arimura A., and Lengvari I. Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23 (2002) 2227-2234
28. Reimer M., Moller K., Sundler F., Hannibal J., Fahrenkrug J., and Kanje M. Increased expression, axonal transport and release of pituitary adenylate cyclase-activating polypeptide in the cultured rat vagus nerve. Neuroscience 88 (1999) 213-222
29. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., and Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (SCID) mice. J Neurosci 19 (1999) RC7
30. Serpe C.J., Tetzlaff J.E., Coers S., Sanders V.M., and Jones K.J. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. Brain Behav Immun 16 (2002) 808-812
31. Suarez V., Guntinas-Lichius O., Streppel M., Ingorokva S., Grosheva M., Neiss W.F., Angelov D.N., and Klimaschewski L. The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. Eur J Neurosci 24 (2006) 1555-1564
32. Suh J., Lu N., Nicot A., Tatsuno I., and DiCicco-Bloom E. PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat Neurosci 4 (2001) 123-124
33. Takei N., Torres E., Yuhara A., Jongsma H., Otto C., Korhonen L., Abiru Y., Skoglosa Y., Schutz G., Hatanaka H., Sofroniew M.V., and Lindholm D. Pituitary adenylate cyclase-activating polypeptide promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo: comparison with effects of nerve growth factor. Eur J Neurosci 12 (2000) 2273-2280
34. Vaudry D., Gonzalez B.J., Basille M., Fournier A., and Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci U S A 96 (1999) 9415-9420
35. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
36. Waschek J.A. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci 24 (2002) 14-23
37. Werner A., Willem M., Jones L.L., Kreutzberg G.W., Mayer U., and Raivich G. Impaired axonal regeneration in alpha7 integrin-deficient mice. J Neurosci 20 (2000) 1822-1830
38. Zhang Q.L., Lin P.X., Shi D., Xian H., and Webster H.D. Vasoactive intestinal peptide: mediator of laminin synthesis in cultured Schwann cells. J Neurosci Res 43 (1996) 496-502
39. Zhang Y., Danielsen N., Sundler F., and Mulder H. Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. Neuroreport 9 (1998) 2833-2836
40. Zhou X., Rodriguez W.I., Casillas R.A., Ma V., Tam J., Hu Z., Lelievre V., Chao A., and Waschek J.A. Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. J Neurosci Res 57 (1999) 953-961